|
2023
|
Invention
|
Methods of administering fviii mimetic bispecific antibodies once monthly |
|
2012
|
Invention
|
Piston rod release mechanism. A release mechanism for a piston (8) /piston rod (14) coupling in a... |
|
2011
|
Invention
|
Stable growth hormone compounds. The present invention relates to growth hormone (GH) compounds h... |
|
2009
|
Invention
|
System for reconstitution of a powdered drug. A mixing system (1) adapted to allow first contents... |
|
|
Invention
|
New blood coagulation factor inhibitors. The invention relates to novel compounds with formula (I... |
|
|
Invention
|
Use of factor viia or factor viia equivalents for preventing or attenuating haemorrhage growth, a... |
|
2008
|
Invention
|
Stabilisation of liquid-formulated factor vii(a) polypeptides by aldehyde-containing compounds. T... |
|
|
Invention
|
Medical mixing device. A drug storage and delivery device (1) comprising a reservoir (102) contai... |
|
|
Invention
|
A method of removing preservatives from a liquid pharmaceutical preparation. The invention relate... |
|
|
Invention
|
Reduction of dimer content in factor vii polypeptide compositions by heat treatment. The present ... |
|
|
Invention
|
Blood coagulation factor inhibitors. The invention relates to novel compounds with formula (I) us... |
|
|
Invention
|
High concentration factor vii polypeptide formulations comprising an aromatic preservative and an... |
|
|
Invention
|
Stabiliser and inhibitors of factor vii. The invention relates to novel compounds with formula (I... |
|
|
Invention
|
Modulating enzymatic processes by addition of diolcontaining substances. The present invention re... |
|
|
Invention
|
C-terminal attachment of two chemical groups to peptides. The present invention relates to a meth... |
|
|
Invention
|
Factor vii polypeptides with increased affinity to platelets. The invention relates to methods fo... |
|
|
Invention
|
Subcutaneous administration of coagulation factor viia-related popypeptdes. The invention relates... |
|
2007
|
Invention
|
Processing enzymes fused to basic protein tags. The invention is related to processing enzyme com... |
|
|
Invention
|
Combination of a fvii and a thrombin-activable factor x. The invention concerns a pharmaceutical ... |
|
|
Invention
|
Transglutaminase variants with improved specificity. Variants of transglutaminase from Streptover... |
|
|
Invention
|
New protein conjugates and methods for their preparation. Reductive amination of peptide-derived ... |
|
|
Invention
|
Factor ix analogues having prolonged in vivo half life. The invention is related to FIX analogues... |
|
|
Invention
|
Covalent factor vii-tissue factor complex. The present invention relates to novel covalent comple... |
|
|
Invention
|
Coupling of polypeptides at the c-terminus. The present invention relates to novel polypeptides, ... |
|
2006
|
Invention
|
Human fvii monoclonal antibodies binding the gla domain and use thereof. The present invention re... |
|
|
Invention
|
Improving transglutaminase substrate specificity. Transglutaminase from S. mobareanse with one or... |
|
|
Invention
|
Transglutaminase mediated conjugation of growth hormone. A method for PEGylating growth hormone, ... |
|
|
Invention
|
New poly(ethylene glycol) derivatives and process for their coupling to proteins. Novel compounds... |
|
|
Invention
|
Blood coagulation fviii analogues. The invention is related to a FVIII analogue which has a circu... |
|
2005
|
Invention
|
Method for preventing formation of trisulfide derivatives of polypeptides. A method for reducing ... |
|
|
Invention
|
Modified proteins. A method of conjugating peptides and proteins by means of glycosyltransferase ... |
|
|
Invention
|
Conjugation of fvii. New FVII polypeptides and FVIIa derivatives, uses of such peptides, and meth... |
|
2003
|
Invention
|
Human coagulation factor vii polypeptides. The present invention relates to novel human coagulati... |
|
|
Invention
|
Stabilised solid compositions of factor vii polypeptides. The invention relates to chemical... |
|
2002
|
Invention
|
Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides. The present ... |
|
|
Invention
|
Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides. The pres... |
|
|
Invention
|
Pharmaceutical composition comprising factor vii polypeptides and tissue plasminogen inhibitors. ... |
|
|
Invention
|
Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides. The pre... |
|
|
Invention
|
Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides. The present... |
|
|
Invention
|
Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors. The prese... |
|
|
Invention
|
Pharmaceutical composition comprising factor vii polypeptides and thrombomodulin polypeptides. Th... |
|
|
Invention
|
Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors. The prese... |
|
|
Invention
|
Pharmaceutical composition comprising factor vii polypeptides and alpha2 -antiplasmin polypeptide... |
|
|
Invention
|
Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to a... |
|
|
Invention
|
Method for production of recombinant proteins in eukaryote cells. The invention provides a method... |
|
|
Invention
|
Coagulation factor vii derivatives. The present invention relates to novel human coagulation Fact... |
|
2001
|
Invention
|
Method for the production of vitamin k-dependent proteins. The present invention relates to... |
